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Aim: We aimed in this study to assess the role of left atrial (LA), in addition to left ventricular (LV) indices, in
predicting exercise capacity in patients with heart failure (HF).
Methods: This study included 88 consecutive patients (60 ± 10 years) with stable HF. LV end-diastolic and end-
systolic dimensions, ejection fraction (EF), mitral and tricuspid annulus peak systolic excursion (MAPSE and
TAPSE), myocardial velocities (s′, e′ and a′), LA dimensions, LA volume and LA emptying fractionweremeasured.
A 6-min walking test (6-MWT) distance was performed on the same day of the echocardiographic examination.
Results: Patientswith limited exercise performance (≤300m)were older (p= 0.01), had higher NYHA function-
al class (p= 0.004), higher LVmass index (p= 0.003), larger LA (p= 0.002), lower LV EF (p= 0.009), larger LV
end-systolic dimension (p = 0.007), higher E/A ratio (p= 0.03), reduced septal MAPSE (p b 0.001), larger LA
end-systolic volume (p = 0.03), larger LA end-diastolic volume (p = 0.005) and lower LA emptying fraction
(p b 0.001) compared with good performance patients. In multivariate analysis, only the LA emptying fraction
[0.944 (0.898–0.993), p = 0.025] independently predicted poor exercise performance. An LA emptying
fraction b60%was 68% sensitive and 73% speciﬁc (AUC 0.73, p b 0.001) in predicting poor exercise performance.
Conclusion: In heart failure patients, the impaired LA emptying function is the best predictor of poor exercise
capacity. This ﬁnding highlights the need for routine LA size and function monitoring for better optimization of
medical therapy in HF.
© 2014 Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Heart failure (HF) is a clinical syndrome, which is becoming a major
problem in public health in recent decades [1,2]. Despite many new
achievements in pharmacological and non-pharmacological treatments,
the morbidity and mortality associated with HF still remain high [2–6].
Several echo-parameters were tested previously [7–15] for clinical
outcome prediction in patients with HF. Different indices were also,
proposed as predictors of survival [11–17], quality of life [11–15] and ex-
ercise capacity [22–26] in these patients. Six-minute walk test (6-MWT)
has been introduced as an accurate tool for assessing exercise capacity
in HF patients, being safe, simple to perform and its results can predict
clinical outcomes [18–21].Angiology, University Clinical
. Tel.: +377 45 800 808.
tari).
nder CC BY-NC-ND license.Left ventricular (LV) systolic function indices [22,23] and those of
global mechanical dyssynchrony [24–26] have been shown to indepen-
dently predict exercise capacity in HF patients. However, the left atrial
(LA) function indices and their relationship with exercise markers
have not been completely tested yet in this setting. Therefore, we
aimed to test LA total emptying fraction as a potential predictor of exer-
cise capacity in HF patients in comparison with other clinical and echo-
cardiographic parameters.
2. Methods
2.1. Study population
We studied 88 patients (mean age 60 ± 10 years, 61% female) with
clinical diagnosis of HF, and New York Heart Association (NYHA) func-
tional class I–class III. Patientswere referred to the Service of Cardiology,
Internal Medicine Clinic, University Clinical Centre of Kosovo, between
February 2013 andNovember 2013. At the time of the study, all patients
were on conventional medical treatment, optimized at least 2 weeks
prior to enrollment, based on patient's symptoms and renal function:
Table 1
Baseline patient's data.
Clinical data
Sex (female, %) 61
Age (years) 60 ± 10
Smoking (%) 21.5
Diabetes (%) 29
Body mass index 29 ± 3.5
Body surface area 1 ± 0.2
Waist/hip ratio 0.95 ± 0.5
NYHA class 1.8 ± 0.8
LBBB 19
Fasting glucose (mmol/L) 7 ± 2.9
Total cholesterol (mmol/L) 4.6 ± 1.2
Triglycerides (mmol/L) 1.7 ± 1
Urea (mmol/L) 8.8 ± 6
Creatinine (mmol/L) 93 ± 29
NYHA: New York Heart Association; LBBB: left bundle branch block.
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diuretics, 77% aspirin and 20.5% Ca-blockers. Of the studied cohort,
19% had ischemic etiology, 65.5% hypertension, 7.14% valve disease
and 8.3% unknown etiology.
Patients with clinical evidence for cardiac decompensation, lim-
ited physical activity due to factors other than cardiac symptoms
(e.g. arthritis), chronic renal failure with a stage N2 (glomerular
ﬁltration rate ≥ 89 mL/min), chronic obstructive pulmonary disease
(COPD) or those with recent acute coronary syndrome, stroke or anemia,
were excluded. Patients gave awritten informed consent to participate in
the study, which was approved by the local Ethics Committee.
2.2. Data collection
Detailed history and clinical assessment were obtained in all patients,
in whom routine biochemical tests were also performed including, lipid
proﬁle, blood glucose level and kidney function tests. Estimated body
mass index (BMI)was calculated fromweight and heightmeasurements.
Waist and hip measurements were also made and waist/hip ratio
calculated.
2.3. Echocardiographic examination
A single operator performed all echocardiographic examinations
using a Philips Intelligent E-33 systemwith amulti-frequency transduc-
er andharmonic imaging as appropriate. Imageswere obtainedwith the
patient in the left lateral decubitus position and during quiet expiration.
LV end-systole and end-diastole dimension measurements were made
from the left parasternal long axis view with the M-mode cursor posi-
tioned by the tips of the mitral valve leaﬂets. LV volumes and EF were
calculated from the apical 2 and 4 chamber views using the modiﬁed
Simpson's method. MAPSE and TAPSE were studied by placing the M-
mode cursor at the lateral and septal angles of the mitral annulus and
the lateral angle of the tricuspid annulus.
Total amplitude of long axis motion (MAPSE or TAPSE) was mea-
sured as previously described [27] from peak inward to peak outward
points. LV and right ventricular (RV) long axis myocardial velocities
were also studied using Doppler myocardial imaging technique. From
the apical 4-chamber view, longitudinal velocities were recorded with
the pulsed wave Doppler sample volume placed at the basal part of LV
lateral and septal segments as well as RV free wall. Systolic (s′) and
early and late (e′ and a′) diastolic myocardial velocities were measured
with the gain optimally adjusted.Mean value of the lateral and septal LV
velocities was calculated.
Diastolic function of the LV and RV was assessed from ﬁlling
velocities using spectral pulsed wave Doppler with the sample volume
positioned at the tips of themitral and tricuspid valve leaﬂets, respective-
ly, during a brief apnea. Peak LV and RV early (E wave) and late (Awave)
diastolic velocities were measured, and E/A ratios were calculated. The
E/e′ ratio was calculated as the ratio between transmitral E wave and
mean lateral and septal e′ wave velocities. The isovolumic relaxation
time was also measured from aortic valve closure to mitral valve open-
ing on the pulsed wave Doppler recording. LV ﬁlling pattern was con-
sidered “restrictive” when E/A ratio was N2.0, E wave deceleration
time b140 ms and the left atrium dilated of more than 40mm in trans-
verse diameter [28].
Mitral regurgitation severity was assessed by color and continuous
wave Doppler and was graded as mild, moderate or severe according
to the relative jet area to that of the left atrium aswell as the ﬂow veloc-
ity proﬁle, in linewith the recommendations of the American Society of
Echocardiography [29]. Likewise, tricuspid regurgitation was assessed
by color Doppler and continuous-wave Doppler. Retrograde trans-
tricuspid pressure drop N35mmHgwas taken as an evidence for pulmo-
nary hypertension [30]. All M-mode and Doppler recordingsweremade
at a fast speed of 100 mm/s with a superimposed ECG (lead II).2.4. Measurements of left atrial dimensions and function
LA diameter was measured from aortic root recordings with the
M-mode cursor positioned at the level of the aortic valve leaﬂets.
LA volumes were measured using area-length method from the api-
cal four and two chamber views, according to the guidelines of the
American Society of Echocardiography [31]. Left atrial maximum
volume (LA end-systolic volume) was measured at the end of LV systo-
le, just before the opening of the mitral valve, LAminimum volume (LA
end-diastolic volume) was measured at end diastole, right after the
closure of the mitral valve, and left atrial total emptying fraction (LA
emptying function) was calculated automatically [31,32].2.5. Six-minute walk test
Within 24 h of the echocardiographic examination, a 6-MWT was
performed on a level hallway surface for all patients and was adminis-
tered by a specialized nurse, blinded to the results of the echocardio-
gram. According to the method of Gyatt et al. [33], patients were
informed of the purpose and protocol of the 6-MWT, which was con-
ducted in a standardized fashionwhile patients on their regularmedica-
tions [34,35]. A 15-m ﬂat, obstacle-free corridor was used, and patients
were instructed to walk as far as they can, turning 180° after reaching
the end of the corridor, during the allocated time of 6 min. Patients
walked unaccompanied so as not to inﬂuence walking speed. At the
end of the 6 min, the supervising nurse measured the total distance
walked by the patient. Pulse and blood pressure were measured before
and at the end of the walking test.2.6. Statistical analysis
Data are presented as mean ± SD or proportions (% of patients).
Continuous data were compared with two-tailed unpaired Student t
test and discrete data with chi-square test. Correlations were tested
with Pearson coefﬁcients. Predictors of 6-MWT distancewere identiﬁed
with univariate analysis, and multivariate logistic regression was per-
formed using the step-wise method. A signiﬁcant difference was de-
ﬁned as p b 0.05 (2-tailed). Patients were divided according to their
ability to walk N300 m into good and limited exercise performance
groups [36] and were compared using unpaired Student t test.3. Results
Patients' mean age was 60 ± 10 years, and 61% were females
(Table 1). The patients group as a whole exercised for a mean of
298 ± 109 m.
Table 3
Comparison of echocardiographic data between patient's groups.
Variable Good performance Limited performance P
(N300 m distance)
N = 45
(≤300 m distance)
N = 43
LV dimensions and mass
LV mass index (g/m 2.7) 50 ± 19 65 ± 26 0.003
LV EDD (cm) 5.1 ± 0.6 5.6 ± 1.3 0.036
LV ESD (cm) 3.4 ± 0.8 4.1 ± 1.5 0.007
IVSd (cm) 1.16 ± 0.3 1.21 ± 0.3 0.5
LVPWd (cm) 0.97 ± 0.1 1.04 ± 0.1 0.04
EDV (ml) 127 ± 27 165 ± 97 0.01
ESV (ml) 54 ± 34 93 ± 86 0.006
LV systolic function
LV ejection fraction (%) 59 ± 12 51 ± 17 0.009
LV shortening fraction (%) 32 ± 8.3 27 ± 11 0.01
MAPSE septal (cm) 1.2 ± 0.2 0.9 ± 0.3 b0.001
Septal s′ (cm/s) 4.8 ± 1.1 4.2 ± 1.2 0.06
MAPSE lateral (cm) 1.3 ± 0.2 1.3 ± 0.3 0.15
Lateral s′ (cm) 5.4 ± 1.3 5.0 ± 1.3 0.18
E/e′ ratio 10 ± 4.7 12 ± 9.0 0.29
LV diastolic function
E wave (cm/s) 58 ± 18 67 ± 24 0.07
A wave (cm/s) 70 ± 16 65 ± 26 0.33
E/A ratio 0.9 ± 0.4 1.3 ± 1.1 0.02
E wave DT (ms) 188 ± 46 160 ± 51 0.01
Lateral e′ (cm/s) 6.4 ± 2.4 7.0 ± 2.8 0.33
Lateral a′ (cm/s) 8.5 ± 2.9 6.6 ± 2.0 0.009
Septal e′ (cm/s) 5.8 ± 1.7 5.5 ± 2.3 0.45
LA dimensions and function
LA diameter (cm) 3.4 ± 0.7 4.6 ± 1.3 0.002
LA transversal diameter (cm) 3.9 ± 0.8 4.7 ± 1.4 0.004
LA longitudinal diameter (cm) 5.7 ± 0.8 6.1 ± 1.3 0.09
LA end systolic volume (ml) 56 ± 36 80 ± 62 0.03
LA end diastolic volume (ml) 23 ± 25 43 ± 40 0.005
LA total EF (%) 62 ± 12 50 ± 16 b0.001
LV: left ventricle; EDD: end-diastolic dimension; ESD: end-systolic dimension; IVSd:
interventricular septum in diastole; PWd: parietal wall in diastole; s′: systolic myocardial
velocity; MAPSE: mitral annular plane systolic excursion; A: atrial diastolic velocity; E:
early diastolic ﬁlling velocity; LA: left atrial; LA total; EF: left atrial total emptying fraction;
DT: deceleration time.
Table 4
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Forty-ﬁve patients had good exercise, and the remaining 43 pa-
tients had limited exercise. Patients with limited exercise capacity
(6-MWT b 300 m) were older (p = 0.01) and had higher creatinine
level (p = 0.03), higher NYHA class (p = 0.004) and lower systolic
and diastolic blood pressure (p = 0.001, for both) compared with
those with good exercise performance (Table 2).
Patients with limited exercise performance also had higher LV mass
index (p= 0.003), larger LA (p= 0.002), lower LV EF (p= 0.009), larger
LV end-systolic dimension (p= 0.007), higher E/A ratio (p= 0.03), re-
duced septal MAPSE (p b 0.001), larger LA end-systolic volume (p =
0.03), larger LA end-diastolic volume (p= 0.005) and lower LA empty-
ing fraction (p b 0.001) compared with good performance patients
(Table 3). Nine of the 43 with limited exercise had restrictive LV ﬁlling
pattern compared to 2 of 45 patients with good exercise performance,
the difference of this incidence between groups was not signiﬁcant.
3.2. Correlation of 6-MWT distance with echo parameters
From the list of echocardiographicmeasurements, only LA emptying
fraction (r= 0.26, p= 0.01), LV EF (r= 0.22, p= 0.03), MAPSE septal
(r= 0.33, p= 0.002) and Septal s′ (r= 0.26, p= 0.02) correlatedwith
the 6-MWT distance (Table 4).
3.3. Predictors of limited 6-MWT distance
From the biochemical and clinical ﬁndings, only age (p= 0.01) and
NYHA class (p= 0.007) predicted limited 6-MWT distance in univari-
ate analysis. However, low LV EF (p = 0.01), higher LV mass index
(p = 0.006), larger LV end-systolic dimension (p = 0.01) and end-
diastolic dimension (p = 0.04), reduced septal MAPSE (p = 0.001),
higher E/A ratio (p = 0.03), larger LA dimension (p = 0.006) and
lower LA emptying fraction (p = 0.001) were univariate echocardio-
graphic predictors of limited exercise capacity (Table 5). Inmultivariate
analysis, only LA emptying fraction [0.944 (0.898–0.993), p= 0.025] in-
dependently predicted poor exercise performance (Table 5). An LA
emptying fraction b60% was 68% sensitive and 73% speciﬁc (AUC 0.73,
p b 0.001) in predicting poor exercise performance (Fig. 1).
4. Discussion
4.1. Findings
Our ﬁndings show that beyond LV EF and its longitudinal systolic
function, the LA emptying function correlatedwith the 6-MWT distanceTable 2
Comparison of clinical and biochemical data between patient's groups.
Variable Good performance Limited performance P
(N300 m distance)
N = 45
(≤300 m distance)
N = 43
Age (years) 58 ± 8.0 63 ± 10 0.01
Body mass index (kg/m2) 29 ± 3.7 28 ± 3.3 0.52
Body surface are 1.1 ± 0.3 1.0 ± 0.2 0.40
Waist/hip ratio 0.95 ± 0.5 0.96 ± 0.5 0.36
SBP (mmHg) 145 ± 24 128 ± 21 0.001
DBP (mmHg) 90 ± 13 81 ± 12 0.001
NYHA class 1.5 ± 0.8 2.1 ± 0.8 0.004
Fasting glucose (mmol/L) 6.1 ± 2.0 7.9 ± 3.9 0.05
Total cholesterol (mmol/L) 4.7 ± 1.2 4.6 ± 1.3 0.83
Tryglycerides (mmol/L) 2.0 ± 1.3 1.5 ± 0.7 0.05
Urea (mmol/L) 7.7 ± 6 10 ± 6 0.12
Creatinine (mmol/L) 82 ± 22 99 ± 32 0.03
Data are mean ± standard deviation. NYHA: New York Heart Association; SBP: systolic
blood pressure; DBP: diastolic blood pressure.in a group of patients with clinically stable HF. It was also the only inde-
pendent predictor of limited exercise capacity, assessed by 6-MWT, in
these patients.Correlations of clinical and echocardiographic variables with 6-min walk distance.
Variable R P
Clinical correlates
Age −0.29 0.01
Body mass index −0.35 0.01
Creatinine −0.06 0.62
Echocardiographic correlates
LA total EF 0.26 0.01
LV ejection fraction 0.22 0.03
E wave velocity −0.09 0.38
A wave velocity 0.01 0.93
E/A ratio −0.13 0.24
E wave DT 0.18 0.09
MAPSE lateral 0.21 0.06
MAPSE septal 0.33 0.002
Septal e′ 0.19 0.07
Septal a′ 0.11 0.32
Septal s′ 0.26 0.02
LV: left ventricle; LA total EF: left atrial total emptying fraction; E: early diastolic ﬁlling
velocity; A: atrial diastolic ﬁlling velocity; E′: early diastolic myocardial velocity; MAPSE:
mitral annular plane systolic excursion.
Table 5
Predictors of limited exercise performance.
Variable Odds ratio (95% CI) P
Clinical univariate predictors
Age 1.066 (1.013–1.122) 0.01
Body mass index 0.958 (0.841–1.092) 0.52
Body surface are 0.410 (0.052–3.254) 0.39
NYHA class 2.346 (1.268–4.341) 0.007
Fasting glucose 1.214 (0.988–1.490) 0.06
Urea 1.097 (0.970–1.240) 0.14
Creatinine 1.026 (0.999–1.053) 0.56
Echocardiographic univariate predictors
LV mass index (g/m 2.7) 1.039 (1.011–1.067) 0.006
LV EDD (cm) 1.047 (1.001–1.095) 0.04
LV ESD (cm) 1.053 (1.011–1.097) 0.01
LV ejection fraction (%) 0.963 (0.935–0.992) 0.01
MAPSE septal (cm) 0.043 (0.007–0.256) 0.001
Septal s′ (cm/s) 0.707 (0.490–1.020) 0.06
MAPSE lateral (cm) 0.317 (0.078–1.293) 0.10
Lateral s′ (cm) 0.796 (0.570–1.111) 0.18
E wave (cm/s) 1.018 (0.998–1.039) 0.08
A wave (cm/s) 0.989 (0.968–1.011) 0.32
E/A ratio 2.313 (1.047–5.111) 0.03
LA diameter (cm) 2.223 (1.260–3.923) 0.006
LA total EF (%) 0.936 (0.902–0.971) b0.001
Multivariate predictors
Age 1.036 (0.970–1.107) 0.29
Gender 1.082 (0.303–3.859) 0.90
NYHA class 1.673 (0.745–3.752) 0.21
LVMI (gm/2.7) 1.013 (0.984–1.044) 0.38
LV EF 1.019 (0.972–1.069) 0.43
MAPSE septal 0.470 (0.043–5.113) 0.53
LA total EF 0.944 (0.898–0.993) 0.02
LV: left ventricle, EDD: end-diastolic dimension, ESD: end-systolic dimension, s′: systolic
myocardial velocity, MAPSE: mitral annular plane systolic excursion, A: atrial diastolic
velocity, E: early diastolic ﬁlling velocity, t-IVT: total isovolumic time, LA: left atrial, LA
total EF: left atrial total emptying fraction.
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The main exercise limiting symptom in heart failure is breathless-
ness, forwhich a number ofmechanismshave been identiﬁed, includingFig. 1. An LA total EF b60% was 68% sensitive and 73% speciﬁc (AUC 0.73, p b 0.001) in
predicting poor exercise performance.compromised stroke volume and cardiac output, raised LV ﬁlling pres-
sures, mitral regurgitation, secondary pulmonary hypertension and in-
adequate peripheral muscle oxygen supply and demand. In our
patients, numerous parameters of cardiac function differentiated the
two groups of patients according to the 6-MW distance. Obviously, LV
global and segmental function were worse in patients with limited
exercise capacity as were markers of ﬁlling pressures; however, the
frequency of patients with restrictive ﬁlling pattern was not different
between the two groups. In addition, the left atrium was signiﬁcantly
larger in patients with limited exercise capacity, and its function was
quite disturbed, as shown by the reduced total emptying fraction with
a value of b60% predicting limited exercise. While the contribution of
low LV ejection fraction to exertional breathlessness is easily under-
stood on the basis of compromised stroke volume [36] and cardiac
output, that of the LV long axis function (MAPSE) requires further expla-
nation. LV long axis function is supported by the longitudinal myocardi-
al ﬁbers located subendocardially. They have been shown to contribute
signiﬁcantly to the overall myocardial fattening and hence contractile
function as shown by thickening fraction and ejection fraction [37]. In
our patients, LV long axis function indeed correlated with exercise
capacity and univariately predicted poor performance. Furthermore,
during exercise, the magnitude of long axis excursion normally in-
creases in order to allow reciprocal increase in left atrial volume and
consequently venous return [38]. This behavior was, again, suboptimal
in our patients because of the abnormal long axis function, at rest, and
the enlarged left atriumwith its stiff myocardium. Finally, the left atrial
emptying function proved to be the only independent predictor of lim-
ited exercise capacity. This could be explained on the basis of the chron-
ically enlarged left atrial cavity with the potential loss of adequate
contractile function, on the plateau of Frank–Starling curve [39,40], irre-
spective of the severity of raised pressures. The perpetual increase of left
atrial pressure secondary to raised LV end-diastolic pressure and mitral
regurgitation results eventually into stretched LA myocardium with
ﬁbrosis, which limits the cavity ability to ﬁll and empty [41]. This causes
pulmonary venous hypertension and consequently breathlessness with
exertion.4.3. Clinical implications
While restrictive LV ﬁlling has beenwell documented as an explana-
tion of exercise intolerance in heart failure, our ﬁndings show that im-
paired LA emptying function, irrespective of restrictive ﬁlling, could
explain patient's exertional breathlessness. Regular incorporation of
LA function assessment in heart failure follow-up protocol should assist
in identifying patients who need aggressive left atrial pressure off-
loading therapy to save them developing restrictive ﬁlling, which in
many patients might be irreversible and is known for its poor clinical
outcome [42]. Our ﬁndings show that LV EF should not be taken solely
as an accurate measure of subtle functional changes in heart failure
patients. Furthermore, our results are supported by Terzi S et al. [43],
who demonstrated similar relationship between LA function and objec-
tive measurements of exercise capacity by VO2.4.4. Limitations
We did not assess left atrial intrinsic myocardial function in this
study, using strain and strain rate measurements. They would have
shed light on explaining our ﬁndings. Our comments on raised left atrial
pressure were based on Doppler ﬁndings, which are well validated,
rather than direct measurements of left atrial pressures, which would
have needed clinically unjustiﬁable invasive techniques. The modest
predictive value of individual measurements might be due to the
small patient's number, as well as the known heterogeneity of this
syndrome.
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In stable heart failure patients, the intrinsic left atrial function seems
to be the best predictor of exercise capacity, assessed by 6-MWT dis-
tance, irrespective of the presence of restrictive ﬁlling pattern. These
ﬁndings suggest a potential use of left atrial emptying fraction as a
sign of early function disturbances, whichmight recover with optimum
adjustment of left atrial pressure ofﬂoading therapy.
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